Results 241 to 250 of about 127,738 (290)

Italian Patients Journey for Gene Therapy in Haemophilia A

Haemophilia, EarlyView.
ABSTRACT Introduction Gene therapy (GT) provides sustained FVIII levels without repeated infusions in Hemophilia A (HA) patients thus overcoming a major limitation of replacement therapy. However, issues remain e.g., patient selection criteria, duration and variability of transgene expression, quality of life and long‐term safety.
Giovanni Di Minno, Gaia Spadarella, Alessandra Borchiellini, Anna Borrelli, Andrea Buzzi, Giancarlo Castaman, Michele Cecchi, Raimondo De Cristofaro, Vincenzo La Mura, Angelo Lupi, Giuseppe Malcangi, Maria Elisa Mancuso, Maria Francesca Mansueto, Cristina Santoro, Rita Carlotta Santoro, Luigi Piero Solimeno, Annarita Tagliaferri, Ezio Zanon, Isabella Garagiola, Flora Peyvandi   +19 more
wiley   +1 more source

Optical immunosensor panel using quantum dot-antibody conjugates for highly sensitive detection of carbohydrate antigen 19–9 (CA19-9)

Daniela Oliveira, Pedro Oliveira, Aiqiang Xu, Eduarda Rodrigues, Susana G. Guerreiro, Rafael C. Castro, David S.M. Ribeiro, João L.M. Santos, Ana M. Piloto   +8 more
openalex   +1 more source

Intratumoral IDH1 mutation status in intrahepatic cholangiocarcinoma is homogeneous

Histopathology, EarlyView.
IDH1 mutations are spatially homogeneous in intrahepatic cholangiocarcinoma. Single‐sample molecular testing is sufficient for clinical decision‐making. Introduction IDH1 mutations occur in approximately 10%–20% of intrahepatic cholangiocarcinoma (iCCA) and constitute an established target for molecularly guided therapy.
Sharon Weidmann, Silvana Ebner, Aayushi Srivastava, Armin Wiegering, Stefan Zeuzem, Peter J. Wild, Maximilian N. Kinzler, Melanie C. Winter, Dirk Walter   +8 more
wiley   +1 more source

Immune Consequences of Metabolic Syndrome and Its Treatment: A Cytokine Perspective

Immunology, EarlyView.
Peripheral blood mononuclear cells (PBMCs) from individuals with metabolic syndrome (MetS) who were not using glucose‐and/or lipid lowering medication (GLLM) exhibited a broader cytokine production profile after in vitro antigen‐specific stimulation than PBMCs from individuals with MetS using such medications and from healthy donors.
Isabela Ghetti Macedo Isaac, Carolina do Prado Servian, Fernanda de Oliveira Feitosa de Castro, João Lucas Lima Calandrini de Azevedo, Ronaldo Moraes Preto, Miriam Leandro Dorta, Daniela Espíndola Antunes, Simone Gonçalves Fonseca   +7 more
wiley   +1 more source

Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study. [PDF]

Int J Surg
Li XL, Liu ZP, Su XX, Gong Y, Yang YS, Zhao XL, Li ZM, Ding JJ, Zhu Y, Yin DL, Yu C, Zhou JX, Zhang D, Ding R, Chen W, Cheng Y, Yue P, Wang ZR, Zhang YQ, Jiang Y, Yin XY, Bai J, Dai HS, Lau WY, Chen ZY, Biliary Surgery Branch of Elite Group of Chinese Digestive Surgery (EGCDS).   +25 more
europepmc   +1 more source

Carbohydrate antigen 19-9 (CA19-9) 産生胃癌の臨床病理学的特徴

, 2016
ヒロシ ヤジマ, Hiroshi YAJIMA, 浩 矢島   +2 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19‐9 and carbohydrate antigen 125

International Journal of Urology, 2005
Abstract  We report a case of advanced renal pelvis and ureter adenocarcinoma producing carcinoembryonic antigen (CEA), carbohydrate antigen 19‐9 (CA19‐9) and carbohydrate antigen 125 (CA125). A 72‐year‐old woman was diagnosed with right renal pelvic and ureter tumor with para‐aortic lymph node swelling.
Takehisa, Onishi, Omar E, Franco, Takuji, Shibahara, Kiminobu, Arima, Yoshiki, Sugimura   +4 more
exaly   +3 more sources

Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)

Clinical Chemistry and Laboratory Medicine (CCLM), 2006
AbstractClin Chem Lab Med 2006;44:1137–9.
Mario, Berth, Eugene, Bosmans, Jacques, Everaert, Jan, Dierick, Johan, Schiettecatte, Ellen, Anckaert, Joris, Delanghe   +6 more
openaire   +2 more sources

Primary Adenocarcinoma of the Ureter Producing Carbohydrate Antigen 19-9

The Journal of Urology, 1996
A 62-year-old man was hospitalized with a history of intermittent hematuria. Excretory urography showed a delayed left nephrogram. Although cytological evaluation of urine indicated transitional cell carcinoma, cystoscopy revealed no visible tumor. Retrograde pyelography on the left side demonstrated a 1.5 cm.
H, Iwaki, Y, Wakabayashi, R, Kushima, Y, Okada, T, Tomoyoshi   +4 more
openaire   +2 more sources

THE CORRELATION OF SERUM CARBOHYDRATE ANTIGEN 19-9 WITH BENIGN HYDRONEPHROSIS

Journal of Urology, 2002
High serum carbohydrate antigen 19-9 in patients with hydronephrosis but without malignant disease is reportedly rare but to our knowledge the clinical features of hydronephrosis that affect this level have not yet been clarified. We examined the correlation of serum carbohydrate antigen 19-9 with hydronephrosis status in patients with benign ...
Kazumi, Suzuki, Osamu, Muraishi, Akihiko, Tokue   +2 more
openaire   +2 more sources